NCI Takes Site-Wide License to Partek Genomic Suite | GenomeWeb
NEW YORK (GenomeWeb News) - The National Cancer Institute has purchased site-wide licenses to Partek’s Genomic Suite, the company announced today.
 
The suite is a statistical and visual data analysis software package that can handle thousands of samples and millions of variables in a genomics experiment, according to Partek.
 
Financial terms of the deal were not released.
 
Every researcher at NCI will have access to the suite as a result of the transaction, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.